Lassa Fever Vaccine Study Supports Advancement to Phase I Trial Medical Countermeasures August 14, 2024 …
Study on Ebola Vaccines and Boosting Regimen Contributes to Future Outbreak Preparedness Medical Countermeasures April 3, 2024 …
Chikungunya Vaccine Candidate Granted Accelerated Review by EMA Medical Countermeasures February 23, 2024 …
People Who Have Previously Had Zika Run Higher Risk of Dengue Landing Them in Hospital Infectious Diseases February 6, 2024 …
Study Shows Potential Benefits of Newer, Non-Egg-Based Flu Vaccines Medical Countermeasures January 31, 2024 …
Promising New ‘circRNA’ Vaccines Explored in CEPI-HMRI Collaboration Medical Countermeasures January 25, 2024 …
Phase 2 Clinical Trial for Marburg Vaccine Starts in Uganda Medical Countermeasures October 19, 2023 …
Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster Medical Countermeasures September 20, 2023 …
Kyasanur Forest Disease: Promising Experimental Vaccine for Rare Tick-borne Flavivirus Medical Countermeasures September 7, 2023 …
Disease X: CEPI and University of Oxford Collaborate on Rapid Response Vaccine Technology Medical Countermeasures August 29, 2023 …
Research Ramps Up to Mitigate Surging Syphilis Rates in the U.S. Infectious Diseases August 29, 2023 …
Allucent Awarded BARDA Contract to Accelerate Next-Generation COVID-19 Booster Vaccines Medical Countermeasures August 28, 2023 …
Imunon Enters into CRADA for Preclinical Studies of PlaCCine Modality in Preventive Vaccines Against Lassa Virus Industry News August 24, 2023 …
Promising Results of Next-Generation Intranasal COVID-19 Booster Vaccine Medical Countermeasures July 20, 2023 …
Bavarian Nordic Awarded DoD Contract to Advance Equine Encephalitis Virus Vaccine Medical Countermeasures December 22, 2022 …
Inovio Considers Moving COVID-19 Vaccine Trial Overseas as U.S. Ends Funding Medical Countermeasures April 23, 2021 …
Vaxxas Awarded $22M to Advance Needle-Free Vaccine Technology for Pandemic Response Industry News October 5, 2020 …
